PIK3CA and breast cancer: Recurrence of the disease was observed in 47 patients (16.6%), and the postoperative recurrence rate was 13.8% (16/116) and 18.6% (31/167) in patients with PIK3CA mutation and wild-type breast cancer, respectively.